Table 2.
Reconstructive Procedure
| Variable | Patients (N = 70) / breasts (N = 101) |
|---|---|
| Mastectomy / reconstruction,a n (%) | |
| Unilateral | 39 (55.7) |
| Bilateral | 31 (44.3) |
| Procedure, n (%) | |
| One stage (direct to implant) | 86 (85.1) |
| Two stages (TE) | 15 (14.9) |
| Implant size (g), mean (SD) | 478.8 (99.6) |
| Total TE expansion (g), mean (SD) | 557.0 (154.1) |
| Implant surface, N = 85, n (%) | |
| Macrotextured | 76 (89.4) |
| Microtextured | 6 (7.1) |
| Nanotextured | 3 (3.5) |
| Contralateral procedure, n (%) | |
| Mastectomy and reconstruction | 62 (61.4) |
| Breast reduction | 5 (5.0) |
| Mastopexy | 3 (3.0) |
| Mastopexy augmentation | 3 (3.0) |
| None | 28 (27.6) |
| Fat injection, n (%) | 26 (25.7) |
| Fat injection (mL), mean (SD) | 157.8 (94.6) |
| Fat injection (number of injections), mean (SD) | 1.2 (0.5) |
| Follow up (years),a mean (SD; range) | 4.9 (2.1; 0.55-8.5) |
a Patients (N = 70). SD, standard deviation; TE, tissue expander.